Literature DB >> 29946010

Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study.

Marios Rossides1, Johan Grunewald2,3,4, Anders Eklund2,3,4, Susanna Kullberg2,3,4, Daniela Di Giuseppe1, Johan Askling1,5, Elizabeth V Arkema1.   

Abstract

Sarcoidosis is believed to be caused by both genetic and environmental risk factors, but the proportion of the susceptibility to sarcoidosis that is mediated by genetics remains unknown. We aimed to estimate the familial aggregation and heritability of sarcoidosis using a case-control-family study design and population-based Swedish registers.We identified 23 880 individuals with visits for sarcoidosis in the Swedish National Patient Register using International Classification of Diseases codes (1964‒2013). Information on Löfgren's syndrome was available for a subset diagnosed at Karolinska University Hospital (Stockholm, Sweden). General population controls were matched to cases (10:1). Relatives of cases and controls were identified from the Swedish Multi-Generation Register and ascertained for sarcoidosis in the National Patient Register. We estimated familial relative risks for sarcoidosis using conditional logistic regression and heritability using biometric models.Having at least one first-degree relative with sarcoidosis was associated with a 3.7-fold increase in the risk of sarcoidosis (95% CI 3.4-4.1). The relative risk increased in those with two or more relatives (relative risk 4.7) and in Löfgren's syndrome (relative risk 4.1). The heritability was 39% (95% CI 12-65%).This large investigation showed that having a relative with sarcoidosis is a very strong risk factor for the disease. Genetic variation is an important, albeit partial, contributing factor to the risk for sarcoidosis.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29946010     DOI: 10.1183/13993003.00385-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Sarcoidosis in Jordan: A Study of the Clinical Phenotype and Disease Outcome.

Authors:  Fatima Alnaimat; Khaled Al Oweidat; Anas Alrwashdeh; Ahmad Alnashrati; Saba Barham; Mohammad Hijaz; Dina Murad; Sameeha Alshelleh; Nathir Obeidat
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

Review 2.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

3.  Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study.

Authors:  Marios Rossides; Susanna Kullberg; Anders Eklund; Daniela Di Giuseppe; Johan Grunewald; Johan Askling; Elizabeth V Arkema
Journal:  Eur Respir J       Date:  2020-09-03       Impact factor: 16.671

4.  Genetic Variants Associated with FDNY WTC-Related Sarcoidosis.

Authors:  Krystal L Cleven; Kenny Ye; Rachel Zeig-Owens; Kerry M Hena; Cristina Montagna; Jidong Shan; H Dean Hosgood; Nadia Jaber; Michael D Weiden; Hilary L Colbeth; David G Goldfarb; Simon D Spivack; David J Prezant
Journal:  Int J Environ Res Public Health       Date:  2019-05-23       Impact factor: 3.390

Review 5.  Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis.

Authors:  Pleiades T Inaoka; Masato Shono; Mishio Kamada; J Luis Espinoza
Journal:  J Biomed Sci       Date:  2019-06-11       Impact factor: 8.410

6.  A Gene-Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis.

Authors:  Natalia V Rivera; Karina Patasova; Susanna Kullberg; Lina Marcela Diaz-Gallo; Tomoko Iseda; Camilla Bengtsson; Lars Alfredsson; Anders Eklund; Ingrid Kockum; Johan Grunewald; Leonid Padyukov
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

Review 7.  Environmental Risk Factors for Sarcoidosis.

Authors:  Marc A Judson
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.